ILMN Illumina Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ILMN

Price (delayed)

$409.15

Market cap

$60.02B

P/E Ratio

77.79

Dividend/share

N/A

EPS

$5.26

Enterprise value

$58.21B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
The quick ratio has soared by 68% YoY and by 36% from the previous quarter
Illumina's EPS has increased by 22% QoQ and by 12% YoY
The stock's price to earnings (P/E) is 34% more than its 5-year quarterly average of 58.1 but 6% less than its last 4 quarters average of 82.8
Illumina's debt has increased by 29% YoY but it has decreased by 16% QoQ
The gross margin has contracted by 2.4% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.illumina.com
Peers: PKI PACB A TMO

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
146.7M
Market cap
$60.02B
Enterprise value
$58.21B
Valuations
Price to earnings (P/E)
77.79
Price to book (P/B)
11.53
Price to sales (P/S)
15.06
EV/EBIT
61.14
EV/EBITDA
50.79
EV/Sales
14.68
Earnings
Revenue
$3.97B
EBIT
$952M
EBITDA
$1.15B
Free cash flow
$898M
Per share
EPS
$5.26
Free cash flow per share
$6.15
Book value per share
$35.48
Revenue per share
$27.16
TBVPS
$51.69
Balance sheet
Total assets
$8.68B
Total liabilities
$3.5B
Debt
$2.38B
Equity
$5.18B
Working capital
$4.44B
Liquidity
Debt to equity
0.46
Current ratio
6.08
Quick ratio
5.52
Net debt/EBITDA
-1.58
Margins
EBITDA margin
28.9%
Gross margin
68.6%
Net margin
19.4%
Operating margin
17%
Efficiency
Return on assets
9.5%
Return on equity
15.8%
Return on invested capital
18.7%
Return on capital employed
12.2%
Return on sales
24%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
-0.59%
1 week
-0.19%
1 month
-5.85%
1 year
25.54%
YTD
10.58%
QTD
0.87%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$3.97B
Gross profit
$2.72B
Operating income
$675M
Net income
$768M
Gross margin
68.6%
Net margin
19.4%
Illumina's operating margin has decreased by 34% YoY
ILMN's net income is up by 22% since the previous quarter and by 11% year-on-year
The operating income has decreased by 22% YoY but it has increased by 16% from the previous quarter
Illumina's revenue has increased by 18% YoY and by 14% QoQ

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
77.79
P/B
11.53
P/S
15.06
EV/EBIT
61.14
EV/EBITDA
50.79
EV/Sales
14.68
The stock's price to earnings (P/E) is 34% more than its 5-year quarterly average of 58.1 but 6% less than its last 4 quarters average of 82.8
Illumina's EPS has increased by 22% QoQ and by 12% YoY
The equity has increased by 14% YoY and by 5% from the previous quarter
The price to book (P/B) is 3.9% higher than the 5-year quarterly average of 11.1
Illumina's revenue has increased by 18% YoY and by 14% QoQ
ILMN's P/S is 13% above its 5-year quarterly average of 13.3 but 6% below its last 4 quarters average of 16.0

Efficiency

How efficient is Illumina business performance
The ROE has grown by 19% from the previous quarter and by 3.9% YoY
The company's return on assets rose by 17% QoQ
Illumina's return on sales has decreased by 13% YoY and by 8% QoQ
ILMN's return on invested capital is up by 7% year-on-year and by 7% since the previous quarter

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 148% more than the total liabilities
The quick ratio has soared by 68% YoY and by 36% from the previous quarter
The current ratio has soared by 62% YoY and by 37% from the previous quarter
Illumina's debt is 54% lower than its equity
Illumina's debt has increased by 29% YoY but it has decreased by 16% QoQ
The debt to equity is down by 19% since the previous quarter but it is up by 15% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.